An Objective Approach to Decisions to Withdraw or Withhold Life-sustaining Medical Treatment.

best interests child futility life-sustaining treatment parens patriae withdrawing treatment withholding treatment

Journal

Journal of law and medicine
ISSN: 1320-159X
Titre abrégé: J Law Med
Pays: Australia
ID NLM: 9431853

Informations de publication

Date de publication:
Oct 2019
Historique:
entrez: 5 11 2019
pubmed: 5 11 2019
medline: 13 11 2019
Statut: ppublish

Résumé

Courts in England and Wales, Australia, and New Zealand have insisted the question of when it is acceptable to withdraw or withhold life-sustaining medical treatment from a child must be considered on a case-by-case basis. Over the last 40 years a number of cases have considered whether treatment is objectively in the child's best interests. This article seeks to identify whether there are factors identified and weighed in a consistent manner across cases. Thirty cases involving decisions about the provision of life-sustaining medical treatment to children three years old or younger were identified. Judges regularly refer to the need to weigh benefits and burdens and these factors were identified and assigned scores. Eight key factors were identified, and a scoring range was assigned to each. The factors focus on the condition and position of the child and the burdens of invasive medical treatment. The review demonstrates there are factors consistently identified and despite criticisms of the indeterminacy of the best interests test, there may be a broadly consistent approach to decision-making. Cognitive capacity and unavoidably imminent death appear to be the two most influential factors in determining whether life-sustaining treatment should be provided.

Identifiants

pubmed: 31682350

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

192-210

Déclaration de conflit d'intérêts

None.

Auteurs

Julian Savulescu (J)

Uehiro Chair in Practical Ethics; Director, Oxford Uehiro Centre for Practical Ethics; Co-Director, Wellcome Centre for Ethics and Humanities, University of Oxford; Law Faculty, University of Melbourne; Visiting Professorial Fellow, Murdoch Children's Research Institute.

James Cameron (J)

PhD Student, Law Faculty, University of Melbourne, supported by Australian Government Research Training Program Scholarship.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH